Liquid Biopsy in Mature B-cell Tumors
ConditionMature B-Cell Neoplasm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOncology Institute of Southern Switzerland
About this trial
The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.
Eligibility criteria
Qualifiers
Male or female adults 18 years or older
Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
Willing and able to comply with scheduled study procedures
Evidence of a signed informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Liquid Biopsy
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov